FDA Fast Tracks BioNTech/DualityBio’s Cancer Drug Candidate
FDA Grants Fast Track Designation to BioNTech and DualityBio for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305 BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Duality Biologics (Suzhou) Co., Ltd. (“DualityBio”) today announced that the U.S. Food…
European Medicines Agency Validates Marketing Authorization Application for Tisotumab Vedotin in Treating Recurrent or Metastatic Cervical Cancer
Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE PFE) have announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for tisotumab vedotin, an antibody-drug conjugate…
Labcorp Introduces Innovative Test for Assessing Risk and Predicting Severity of Preeclampsia in Expectant Mothers
Labcorp (NYSE: LH), a renowned provider of cutting-edge and all-encompassing laboratory services globally, has introduced and made accessible a recently FDA-cleared blood test. This test is designed for evaluating the…
Verification of Gamma Wave Synchronization in the Human Brain via Auditory Stimulation: Academic Session at Neuroscience 2023 in the United States
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; referred to as “Shionogi”) has revealed that Pixie Dust Technologies, Inc. (Head Office: Tokyo, Japan; Representative…
Bio-Techne Unveils Fiscal 2024 Second Quarter Financial Performance
Bio-Techne Corporation (NASDAQ: TECH) has released its financial results for the second quarter ending December 31, 2023. Key Highlights for the Second Quarter of Fiscal Year 2024: Bio-Techne’s financial statements…
Advanced Cell Diagnostics by Bio-Techne Establishes a New Benchmark in Spatial Biology with Protease-Free RNAscope Multiomics
Bio-Techne Corporation (NASDAQ: TECH) has unveiled a groundbreaking achievement, as its spatial biology brand, Advanced Cell Diagnostics (ACD), sets a new industry standard. The innovation comes in the form of…
Teva Plans API Business Divestment as a Key Element of Growth-Oriented Strategy
Teva Announces Plan to Sell its Active-Pharmaceutical Ingredient (API) Business, ‘TAPI,’ as a Strategic Move Towards Growth Teva disclosed today its decision to divest its active-pharmaceutical ingredient (API) business, known…
Grifols Appoints New Senior Leadership Team
Grifols, a distinguished global healthcare company with a 115-year legacy as a leading manufacturer of plasma-derived medicines, has bolstered its senior management team through two strategic appointments. Dr. Roland Wandeler…
Staying Alert and Taking Precautions During Lunar New Year Celebrations Amidst Avian Influenza Concerns
Enhanced Precautions and Vigilance for Avian Influenza during Lunar New Year Celebrations in Asia As preparations for Lunar New Year festivities in Asia gain momentum, the increased trading and handling…
Rising Global Cancer Cases Highlight Increasing Demand for Healthcare Services
In anticipation of World Cancer Day, the International Agency for Research on Cancer (IARC), the cancer agency of the World Health Organization (WHO), has unveiled the latest global cancer burden…
Atara Biotherapeutics and Pierre Fabre Laboratories Release Phase 3 ALLELE Tab-cel® Results in The Lancet Oncology
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, and Pierre Fabre…
ROHTO Pharmaceutical Forges Global Aesthetics Market Entry Through Long-Term Strategic and Equity Partnership with EMA Aesthetics
ROHTO Pharmaceutical Strengthens Global Presence with EMA Aesthetics Through Strategic Partnership EMA Aesthetics, a Dublin-based global aesthetics company, has announced a significant strategic and equity collaboration with ROHTO Pharmaceutical, a…